
Auteur E. FORTIER
|
Documents disponibles écrits par cet auteur (3)

E. FORTIER ; S. B. HOJ ; M. P. SYLVESTRE ; A. A. ARTENIE ; N. MINOYAN ; D. JUTRAS-ASWAD ; J. GREBELY ; J. BRUNEAU | 2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : PériodiqueBackground: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may affect HCV infection risk. Thus, this study[...]Nouveauté
A. A. ARTENIE ; G. ZANG ; M. DANIEL ; E. FORTIER ; D. JUTRAS-ASWAD ; S. PUZHKO ; J. BRUNEAU | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueBackground: It is unclear whether treatment and care for hepatitis C virus (HCV) infection can help people who inject drugs (PWID) modify their injection drug use behaviours. This study examined changes in injection drug use among PWID with acut[...]
A. A. ARTENIE ; E. FORTIER ; M. P. SYLVESTRE ; S. B. HOJ ; N. MINOYAN ; L. GAUVIN ; D. JUTRAS-ASWAD ; J. BRUNEAU | 2021
Dans International Journal of Drug Policy (Vol.94, August 2021) Article : PériodiqueBackground: Little is known about how socioeconomic circumstances relate to injection frequencies among people who inject drugs (PWID) with diverse trajectories of injection. We aimed to characterize trajectories of injection drug use in a commu[...]